144 related articles for article (PubMed ID: 3281723)
1. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67.
Grogan TM; Lippman SM; Spier CM; Slymen DJ; Rybski JA; Rangel CS; Richter LC; Miller TP
Blood; 1988 Apr; 71(4):1157-60. PubMed ID: 3281723
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of Ki-67 antigen in non-Hodgkin lymphoma of Waldeyer ring and the nasal cavity.
Yamanaka N; Harabuchi Y; Kataura A
Cancer; 1992 Nov; 70(9):2342-9. PubMed ID: 1394063
[TBL] [Abstract][Full Text] [Related]
3. Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma.
Bevilacqua P; Verderio P; Barbareschi M; Bonoldi E; Boracchi P; Dalla Palma P; Gasparini G
Breast Cancer Res Treat; 1996; 37(2):123-33. PubMed ID: 8750580
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial.
Miller TP; Grogan TM; Dahlberg S; Spier CM; Braziel RM; Banks PM; Foucar K; Kjeldsberg CR; Levy N; Nathwani BN
Blood; 1994 Mar; 83(6):1460-6. PubMed ID: 8123837
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma.
Llanos M; Alvarez-Argüelles H; Alemán R; Oramas J; Diaz-Flores L; Batista N
Med Oncol; 2001; 18(1):15-22. PubMed ID: 11778965
[TBL] [Abstract][Full Text] [Related]
6. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype.
Lippman SM; Miller TP; Spier CM; Slymen DJ; Grogan TM
Blood; 1988 Aug; 72(2):436-41. PubMed ID: 3261181
[TBL] [Abstract][Full Text] [Related]
8. Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma.
Offit K; Ladanyi M; Gangi MD; Ebrahim SA; Filippa D; Chaganti RS
Leukemia; 1990 Sep; 4(9):625-30. PubMed ID: 2168505
[TBL] [Abstract][Full Text] [Related]
9. Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells.
Jovanović MP; Jaković L; Bogdanović A; Marković O; Martinović VC; Mihaljević B
Vojnosanit Pregl; 2009 Sep; 66(9):738-43. PubMed ID: 19877554
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International Index.
Ansell SM; Kurtin PJ; Stenson M; Habermann TM; Greipp PR; Therneau TM; Witzig TE
Leuk Lymphoma; 1999 Aug; 34(5-6):529-37. PubMed ID: 10492076
[TBL] [Abstract][Full Text] [Related]
11. Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases.
Chott A; Kaserer K; Augustin I; Vesely M; Heinz R; Oehlinger W; Hanak H; Radaszkiewicz T
Am J Surg Pathol; 1990 May; 14(5):439-48. PubMed ID: 2158242
[TBL] [Abstract][Full Text] [Related]
12. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB; Iversen OE; Akslen LA
Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1.
Kreipe H; Alm P; Olsson H; Hauberg M; Fischer L; Parwaresch R
Am J Pathol; 1993 Feb; 142(2):651-7. PubMed ID: 8094598
[TBL] [Abstract][Full Text] [Related]
14. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
Cordone I; Matutes E; Catovsky D
Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694
[TBL] [Abstract][Full Text] [Related]
16. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
Veronese SM; Maisano C; Scibilia J
Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
[TBL] [Abstract][Full Text] [Related]
17. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
Richendollar BG; Pohlman B; Elson P; Hsi ED
Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of Ki67 antigen using MIB1 antibody as a prognostic factor in renal pelvic and ureteral cancer].
Kojima K; Naruo S; Kanayama H; Kagawa S
Nihon Hinyokika Gakkai Zasshi; 1996 May; 87(5):822-30. PubMed ID: 8691707
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma.
Romaguera JE; Manning JT; Tornos CS; Rodriguez J; Brooks TE; Pugh WC; Ordonez NG; Goodacre AM; Cabanillas F
Ann Oncol; 1994 Apr; 5(4):317-22. PubMed ID: 8075027
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of immunologic phenotype in diffuse large cell lymphoma.
Horning SJ; Doggett RS; Warnke RA; Dorfman RF; Cox RS; Levy R
Blood; 1984 May; 63(5):1209-15. PubMed ID: 6370335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
